AEGERA THERAPEUTICS

aegera-therapeutics-logo

Aegera Therapeutics is a clinical stage biotechnology company focused on developing targeted therapeutics to address major unmet medical needs. Aegera has three programs in clinical development, two for oncology and one for neuropathic pain. Aegera is also dedicated to identifying novel development candidates based upon its core technologies and internal expertise and experience in rapidly moving lead candidates through preclinical development and into clinical trials.

#People #Financial #Website #More

AEGERA THERAPEUTICS

Social Links:

Industry:
Biotechnology Health Care Pharmaceutical

Founded:
1997-01-01

Address:
Montrรฉal, Quebec, Canada

Country:
Canada

Website Url:
http://www.aegera.com

Total Employee:
11+

Status:
Closed

Contact:
(514) 288-553

Total Funding:
35.63 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Mobile Non Scaleable Content Microsoft Exchange Online Office 365 Mail IPv6 Cloudflare Cloudflare Hosting Cloudflare Network Error Logging



Current Advisors List

joseph-regan_image

Joseph Regan Member of the Board of Directors @ Aegera Therapeutics
Board_member

Current Employees Featured

jacques-jolivet_image

Jacques Jolivet
Jacques Jolivet Senior Vice-President of Clinical Development @ Aegera Therapeutics
Senior Vice-President of Clinical Development

not_available_image

Michael Atkin
Michael Atkin Founder & CEO @ Aegera Therapeutics
Founder & CEO

Founder


not_available_image

Michael Atkin

Acquisitions List

Date Company Article Price
2007-08-08 LymphoSign LymphoSign acquired by Aegera Therapeutics N/A

Investors List

business-development-bank-of-canada_image

Business Development Bank of Canada

Business Development Bank of Canada investment in Series C - Aegera Therapeutics

desjardins-venture-capital_image

Desjardins Venture Capital

Desjardins Venture Capital investment in Series C - Aegera Therapeutics

multiple-capital_image

Multiple Capital

Multiple Capital investment in Series C - Aegera Therapeutics

vengrowth-asset-management_image

VenGrowth Asset Management

VenGrowth Asset Management investment in Series C - Aegera Therapeutics

growthworks_image

GrowthWorks Capital

GrowthWorks Capital investment in Series C - Aegera Therapeutics

canadian-medical-discoveries-fund_image

Canadian Medical Discoveries Fund

Canadian Medical Discoveries Fund investment in Venture Round - Aegera Therapeutics

business-development-bank-of-canada_image

Business Development Bank of Canada

Business Development Bank of Canada investment in Venture Round - Aegera Therapeutics

genechem_image

GeneChem

GeneChem investment in Venture Round - Aegera Therapeutics

innovatech-du-grand-montreal_image

Innovatech Grand Montreal

Innovatech Grand Montreal investment in Venture Round - Aegera Therapeutics

Official Site Inspections

http://www.aegera.com

  • Host name: 104.21.86.104
  • IP address: 104.21.86.104
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Aegera Therapeutics" on Search Engine